Patients who took a daily dose of the drug, baxdrostat, were able to reduce their blood pressure substantially, compared to a people who got a placebo, according to the study published in the New England Journal of Medicine and presented at the American Heart Association annual meeting on Monday. The new type of oral medication works by targeting a hormone that regulates the amount of salt in the body.